$69.38
-4.42-5.99%
Last update: Jun 2, 12:41 PM
PTC Therapeutics Inc Earnings Estimates
PTCTNASDAQ
PTC Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:PTCT
PTC Therapeutics (PTCT) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $0.26 and quarterly revenue of $288.98M.
In the most recent quarter (Q1), PTC Therapeutics reported EPS of $-0.03, beating estimates of $-0.41 by 0.93%. Revenue came in at $272.55M, exceeding the estimate of $227.52M by 0.20%.
Over the last 4 quarters, PTC Therapeutics has averaged an EPS surprise of 1.60% and a revenue surprise of 0.22%.
Earnings Date
Aug 6
EPS Estimate
$0.260
Quarterly Revenue Estimate
$288.98M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$827.11M
PTC Therapeutics Earnings History
Analyze the earnings history of PTC Therapeutics using advanced sorting and filters.
Loading calendar...
PTC Therapeutics (PTCT) Earnings Per Share
The chart below shows PTC Therapeutics's reported EPS compared to analyst estimates over recent quarters.
PTC Therapeutics (PTCT) Revenue
The chart below shows PTC Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is PTC Therapeutics (NASDAQ:PTCT) reporting earnings?
PTC Therapeutics (PTCT) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for PTC Therapeutics (NASDAQ:PTCT)?
The Actual EPS was $-0.03, which beat the estimate of $-0.41.
What were PTC Therapeutics’s (NASDAQ:PTCT) revenues?
The Actual Revenue was $272.55M, which beat the estimate of $227.52M.
